The prognostic role of Bcl-2, Ki67, c-MYC and p53 in diffuse large B-cell lymphoma

Vol. 58 No. 3, 2017

ROMANIAN JOURNAL of MORPHOLOGY and EMBRYOLOGY

Ana-Maria Patrascu, Ionela Rotaru, Lavinia Olar, Stefan Patrascu, Mirela-Corina Ghilusi, Simona-Daniela Neamtu, Janina Georgiana Nacea, Adrian Gluhovschi

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphoid malignancies, which counts for more than a third of non-Hodgkin s lymphoma cases. The aim of the current study is to evaluate the prognostic role of several immunohistochemical (IHC) markers involved in the pathological process of DLBCL. This is a retrospective analysis of the 97 de novo DLBCL patients admitted between January 2007 and December 2016 in the Department of Hematology, Filantropia Municipal Hospital, Craiova, Romania. The expression of Bcl-2, Ki67, c-MYC and p53 was assessed by immunohistochemistry. A significant level of association was observed between high prognostic index values and Bcl-2, Ki67, c-MYC and p53 positive cases. Moreover, overall survival and disease-free survival were higher in patients with negative expression for these markers. Bcl-2, Ki67, c-MYC and p53 could make important diagnostic and therapeutic targets; therefore, their routine assessment should be mandatory.

Corresponding author: Stefan Patrascu, Teaching Assistant, MD, PhD; e-mail: stef.patrascu@gmail.com

Download PDF
Download cover
Download contents

Journal archive